Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis
Respirology · 2025
DOI: 10.1111/resp.70099 ↗At a glance
Kohortenstudie in Respirology, 2025. Written by Xinru Ran and 23 co-authors. Institution: Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Gu…. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Matrix Metalloproteinase 9, Lung. Cited 1 times so far (Crossref); 37 references. Funded by: The Foundation of Guangzhou National Laboratory, The Foundation of Guangzhou Basic and Applied Basic Research Scheme, The Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease.
Topics: COPD
Abstract (original language)
Background and Objective The imbalance in proteases/antiproteases caused by inflammation contributes to COPD, and matrix metalloproteinase‐9 (MMP‐9) may play an important role. Therefore, we aimed to investigate the associations of MMP‐9 with respiratory health outcomes.
Methods
This study was conducted in two parts. Firstly, we performed a prospective cohort study to investigate the association of circulating MMP‐9 and respiratory health outcomes. Participants completed a questionnaire, spirometry, and chest CT, and provided blood samples at baseline. Follow‐up visits were conducted annually. Study outcomes were the development of spirometry‐defined COPD, lung function decline, and exacerbations. Secondly, we performed a two‐sample Mendelian randomisation (MR) study to evaluate the causal effect between genetically predicted MMP‐9 expression and lung function.
Results
Overall, 1328 participants were included in the baseline analysis, and 1034 (78%) completed the 2‐year follow‐up. Higher plasma MMP‐9 at baseline was associated with chronic respiratory symptoms, severe emphysema, and air trapping. During the 2‐year follow‐up, each SD increase in plasma MMP‐9 was associated with accelerated decline in pre‐bronchodilator FEV 1 (adjusted difference = 6.4 [95% CI: 0.7–12.1] mL/year) and FVC (adjusted difference = 18.0 [95% CI: 7.6–28.5] mL/year), and a higher exacerbation incidence. In participants with normal spirometry at baseline, higher plasma MMP‐9 was associated with progression to spirometry‐defined COPD (adjusted OR = 1.93, 95% CI: 1.05–3.57). A MR study demonstrated similar results toward negative associations of genetically predicted MMP‐9 expression with FEV 1 and FVC.
Conclusion
The longitudinal cohort and MR study provide evidence that MMP‐9 might play a causative role in lung function decline and spirometry‐defined COPD development. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China.
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospit…
- Guangzhou National Laboratory, Guangzhou, China.
- The First Clinical College of Guangzhou Medical University, Guangzhou, China.
ORCID profiles: Fan Wu, Zihui Wang, Huajing Yang, Cuiqiong Dai, Lifei Lu, Kunning Zhou, Pixin Ran, Yumin Zhou
Funding
- The Foundation of Guangzhou National Laboratory
- The Foundation of Guangzhou Basic and Applied Basic Research Scheme
- The Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease
- The National Natural Science Foundation of China
- Major Clinical Research Project of Guangzhou Medical University's Scientific Research Capability Improvement Plan
- the Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
Cite
APA
Ran, X., Wu, F., Wang, Z., Li, H., Deng, Z., Zhou, Q., Yang, H., Zheng, Y., Zhao, N., Dai, C., Tang, G., Wu, X., Wan, Q., Peng, J., Lu, L., Zhou, K., Bai, G., Cui, J., Zhang, Y., …, & Zhou, Y. (2025). Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis. Respirology. https://doi.org/10.1111/resp.70099
Vancouver
Ran X, Wu F, Wang Z, Li H, Deng Z, Zhou Q, et al. Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis. Respirology. 2025. doi:10.1111/resp.70099
BibTeX
@article{Ran2025,
author = {Ran, Xinru and Wu, Fan and Wang, Zihui and Li, Haiqing and Deng, Zhishan and Zhou, Qiaorui and Yang, Huajing and Zheng, Youlan and Zhao, Ningning and Dai, Cuiqiong and Tang, Gaoying and Wu, Xiaohui and Wan, Qi and Peng, Jieqi and Lu, Lifei and Zhou, Kunning and Bai, Ge and Cui, Jieda and Zhang, Yang and Ke, Maomao and Han, Wenya and Sun, Ruiting and Ran, Pixin and Zhou, Yumin},
title = {Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.70099}
}
EUVIMED